What causes dryness in Sjögren's syndrome patients and how can it be targeted?

References

• Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea 1998;17(6):584-9
   PubMed Web of Science ®Google Scholar
• Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013;32(1):19-41
   PubMed Web of Science ®Google Scholar
• Humphreys-Beher MG, Brinkley L, Purushotham KR, et al. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice. Clin Immunol Immunopathol 1993;68(3):350-6
   PubMedGoogle Scholar
• Kovacs L, Marczinovits I, Gyorgy A, et al. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3 in primary Sjogren's syndrome. Rheumatology 2005;44(8):1021-5
   PubMed Web of Science ®Google Scholar
• Zoukhri D, Macari E, Kublin CL. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp Eye Res 2007;84(5):894-904
   PubMed Web of Science ®Google Scholar
• Rahimy E, Pitcher JD 3rd, Pangelinan SB, et al. spontaneous autoimmune dacryoadenitis in aged CD25KO. Am J Pathol 2010;177(2):744-53
   PubMed Web of Science ®Google Scholar
• Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf 2009;7(1):11-27
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, et al. Pro- and anti- inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci 2001;42(10):2283-92
   PubMed Web of Science ®Google Scholar
• Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol 2009;147(2):198-205
   PubMed Web of Science ®Google Scholar
• Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010;51(12):6125-30
   PubMed Web of Science ®Google Scholar
• Alex A, Edwards A, Hays JD, et al. Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci 2013;54(5):3325-32
   PubMed Web of Science ®Google Scholar
• Stern ME, Schaumburg CS, Dana R, et al. Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol 2010;3(5):425-42
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC. Tear dysfunction and the Cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol 2011;152(6):900-9
   PubMed Web of Science ®Google Scholar
• Sobrin L, Selzer MG, Lokeshwar BL, et al. Stromelysin (MMP-3) activates pro-MMP-9 secreted by corneal epithelial cells. Invest Ophthalmol Vis Sci 2000;41(7):1703-9
   PubMed Web of Science ®Google Scholar
• Chotikavanich S, de Paiva CS, Li DQ, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50(7):3203-9
   PubMed Web of Science ®Google Scholar
• Jones DT, Yen M, Monroy D, et al. Sjögren's syndrome: cytokine and Epstain-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994;35(9):3493-504
   PubMed Web of Science ®Google Scholar
• Quarta S, Vogl C, Constantin CE, et al. Genetic evidence for an essential role of neuronally expressed IL-6 signal transducer gp130 in the induction and maintenance of experimentally induced mechanical hypersensitivity in vivo and in vitro. Mol Pain 2011;7(9):73
   PubMedGoogle Scholar
• De Paiva CS, Chotikavanich S, Pangelinan SB, et al. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009;2(3):243-53
   PubMed Web of Science ®Google Scholar
• Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009;82(3):1247-52
   Google Scholar
• DePaiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci 2007;48(6):2553-60
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Corrales RM, de Paiva CS. T helper cytokines in dry eye disease. Exp Eye Res 2013;117:118-25
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen W, De Paiva CS, et al. Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci 2011;52(9):6279-85
   PubMed Web of Science ®Google Scholar
• Yoon KC, De Paiva CS, Qi H, et al. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci 2007;48(6):2561-9
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, De Paiva CS, Villarreal AL, et al. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production. Cornea 2008;27(1):4-9
   Web of Science ®Google Scholar
• Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004;138(3):444-57
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Corrales RM, Villarreal AL, et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci 2006;47(7):2847-56
   PubMed Web of Science ®Google Scholar
• Zhang X, De Paiva CS, Su Z, et al. Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye Exp Eye Res. 2014;118:117-24
   Google Scholar
• Amparo F, Dastjerdi MH, Okanobo A, et al. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. JAMA Ophthalmol 2013;131(6):715-23
   PubMed Web of Science ®Google Scholar